Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BNTC

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 0.020 %
Consecutive Years 0
Forward Annual Dividend 0.0030 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 01.06.2018

Benitec Biopharma Ltd ADR

BNTC
Current price
13.84 USD +0.86 USD (+6.63%)
Last closed 12.62 USD
ISIN US08205P2092
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 345 719 072 USD
Yield for 12 month +44.92 %
1Y
3Y
5Y
10Y
15Y
BNTC
21.11.2021 - 28.11.2021

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California. Address: 3940 Trust Way, Hayward, CA, United States, 94545

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25.71 USD

P/E Ratio

Dividend Yield

Financials BNTC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+141 501 USD

Last Year

+49 132 USD

Current Quarter

Last Quarter

Current Year

+70 750 USD

Last Year

-200 459 USD

Current Quarter

Last Quarter

EBITDA -30 059 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -31.34 %
PEG Ratio
Return On Equity TTM -48.57 %
Wall Street Target Price 25.71 USD
Revenue TTM 7 000 USD
Book Value 3.82 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.50 %
Dividend Yield
Gross Profit TTM
Earnings per share -5.03 USD
Diluted Eps TTM -5.03 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 10 457.68
Price Sales TTM 2 770.13
Enterprise Value EBITDA 0.27
Price Book MRQ 3.54

Technical Indicators BNTC

For 52 Weeks

7.05 USD 17.15 USD
50 Day MA 14.27 USD
Shares Short Prior Month 445 550
200 Day MA 12.10 USD
Short Ratio 11.28
Shares Short 527 600
Short Percent 3.68 %